Walden Group Healthcare M&A Blog

  • The Impact of Trump’s Tariffs

    08/07/2018
    President Trump’s tariffs on Chinese imports could cost American medical device makers more than $1.5b annually, according to some estimates. MRIs, CT scanners, pacemakers, sonograms and other imaging components were all included in the list of items subject to the 25% tariffs that went into effect on June 6. Also included are a variety of...
    Read More
  • Celgene Acquires Juno Therapeutics For $9b

    07/18/2018
    Celgene Corp., a $12.5b developer of therapies for cancer and inflammatory diseases is buying Juno Therapeutics Inc., a Seattle-based biotech company making cutting-edge cancer immunotherapy treatments. The Deal expands Celgene’s portfolio of blood-cancer drugs. Juno is one of leaders in a new kind of cancer treatment, known as CAR-T, that...
    Read More
  • Sweeping New EU Regulations, Taking Effect in 2020, Will Create Upheavals in The European Medtech and IVD Markets

    07/11/2018
    Starting in 2020 medtech firms will be competing in a significantly more complicated European market. New Medical Devices Regulations (MDR) were written to strengthen device safety standards but they will make it far more onerous and expensive for medtech firms to market their products in Europe.  Because of the MDR, many smaller companies may...
    Read More
  • Novartis, Abbott, GE, Siemens, and Other Healthcare Giants Are Reversing Previous Diversification Strategies

    07/11/2018
      Novartis/Alcon After assessing strategic options for Alcon, Novartis is spin-ning it out to shareholders. As a result, both companies will now rivet on their core strengths –pharmaceuticals and oph-thalmic devices, respectively. When Novartis acquired Alcon in 2011 for $52b, the business included surgical, vision care and ophthalmic...
    Read More
  • Sivantos and Widex Announce Merger

    05/31/2018
    Sivantos, a Germany-based hearing aid maker previously owned by Siemens will merge with Widex, a Denmark-based hearing aid maker to form a company with an enterprise value of more than $8b. Sivantos, owned by EQT Partners, and Widex are merging to form the 3rd largest hearing aid maker. The merger will likely push back EQT’s plans for an...
    Read More